Pages that link to "Q37355727"

The following pages link to Potential new drug targets for osteoporosis (Q37355727):

Displaying 49 items.

• Nuclear receptors in bone physiology and diseases (Q26853017) (← links)
• The osteocyte as a therapeutic target in the treatment of osteoporosis (Q27009129) (← links)
• Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and its Role in Treatment of Osteoporosis (Q28077985) (← links)
• Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo (Q30914003) (← links)
• Metabolism-guided design of short-acting calcium-sensing receptor antagonists (Q33557940) (← links)
• Profile of romosozumab and its potential in the management of osteoporosis (Q33596475) (← links)
• Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis (Q33720171) (← links)
• A roadmap to the brittle bones of cystic fibrosis (Q34442832) (← links)
• The effect of cathepsin K deficiency on airway development and TGF-β1 degradation. (Q35073995) (← links)
• The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model (Q35080134) (← links)
• Effects of age on parathyroid hormone signaling in human marrow stromal cells. (Q35171161) (← links)
• Pharmacogenomics in osteoporosis: Steps toward personalized medicine (Q36441461) (← links)
• Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway (Q37203221) (← links)
• Activin signaling as an emerging target for therapeutic interventions (Q37268461) (← links)
• Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. (Q37282934) (← links)
• Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway (Q37448267) (← links)
• Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients (Q37577926) (← links)
• Emerging therapeutic targets in breast cancer bone metastasis (Q37658767) (← links)
• (-)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via Runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation (Q37683413) (← links)
• Specialized roles for cysteine cathepsins in health and disease. (Q37797839) (← links)
• Antagonism of Activin by Activin Chimeras (Q37847427) (← links)
• Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates (Q37862933) (← links)
• Osteoporosis in older persons: current pharmacotherapy and future directions (Q38124052) (← links)
• Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H( )-ATPase as an emerging target (Q38205860) (← links)
• New Target Sites for Treatment of Osteoporosis (Q39151180) (← links)
• Estrogen-like and tissue-selective effects of 7-methoxycoumarin from Ficus umbellata (Moraceae): an in vitro and in vivo study (Q41229029) (← links)
• Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis (Q41943716) (← links)
• Effect of parathyroid hormone on healing in osteoporotic fractures via a phospholipase C-independent pathway (Q42110404) (← links)
• Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells (Q42481456) (← links)
• Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists) (Q42946642) (← links)
• Taurine promotes human mesenchymal stem cells to differentiate into osteoblast through the ERK pathway (Q46285303) (← links)
• An Innovative Intramedullary Nail for Stabilizing Mouse Femoral Defects (Q46394575) (← links)
• Dietary dried plum increases bone mass in adult and aged male mice (Q46687955) (← links)
• Baculovirus-Mediated miR-214 Knockdown Shifts Osteoporotic ASCs Differentiation and Improves Osteoporotic Bone Defects Repair (Q47104231) (← links)
• Dual roles of QOA-8a in antiosteoporosis: a combination of bone anabolic and anti-resorptive effects. (Q47785875) (← links)
• Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study. (Q47966083) (← links)
• The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts (Q48079300) (← links)
• Panax notoginseng saponins promote osteogenic differentiation of bone marrow stromal cells through the ERK and P38 MAPK signaling pathways (Q50527466) (← links)
• A Root-Based Combination Supplement Containing Pueraria lobata and Rehmannia glutinosa and Exercise Preserve Bone Mass in Ovariectomized Rats Fed a High-Fat Diet (Q50990582) (← links)
• Sialoglycoproteins prepared from the eggs of Carassius auratus prevent bone loss by inhibiting the NF-κB pathway in ovariectomized rats. (Q51562477) (← links)
• Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats. (Q53801779) (← links)
• Protective Effects of Selected Botanical Agents on Bone. (Q55040816) (← links)
• Matrix Proteases and the Degradome (Q57082617) (← links)
• Microporous polysaccharide multilayer coated BCP composite scaffolds with immobilised calcitriol promote osteoporotic bone regeneration both in vitro and in vivo (Q64238230) (← links)
• Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment. (Q64905011) (← links)
• Bone adaptation in osteoporosis (Q84148670) (← links)
• The effects of bisphosphonates on osteonecrosis of jaw bone: a stem cell perspective (Q90146058) (← links)
• Parathyroid hormone ameliorates temporomandibular joint osteoarthritic-like changes related to age (Q90183714) (← links)
• Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway (Q92496051) (← links)